Brief: Sinopharm Group Announces A Memorandum Of Joint Venture Cooperation
Dec 8 (Reuters) - Sinopharm Group Co Ltd 1099.HK :
* CHINA NATIONAL MEDICAL DEVICE CO & QINGDAO NOVELBEAM
TECHNOLOGY
CO ENTERED A MEMORANDUM OF JOINT VENTURE COOPERATION
* MEMORANDUM FOR ESTABLISHMENT OF A JV
* TOTAL REGISTERED CAPITAL OF JOINT VENTURE IS RMB160
MILLION
* CNMDC AND NOVELBEAM TO ESTABLISH A JV BY WAY OF CASH
CONTRIBUTION WITH A RATIO OF 51:49
Source text for Eikon: ID:nHKS3L4Jrp
Further company coverage: 1099.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinopharm
See all newsBrief: Sinopharm Group Says 9M Sinopharm Accord Net Income Attributable RMB952.5 Million (Oct 20)
Medical products distributor Sinopharm Group's prelim 9-month revenue slips
Brief: BlackRock's Long Position In H Shares Of Sinopharm Reduces To 9.23% On Oct 13, HKEX Shows
Sinopharm interim revenue edges down on softness in pharmaceutical distribution business
Brief: Sinopharm Group To Sell 30.13% Stake In China National Medicines Guorui Pharmaceutical For